modafinil sleep apnea
This page on modafinil sleep apnea covers one abstract.
The paper is a review and meta-analysis.
They pooled all randomised trials in res-OSA.
They looked at efficacy and safety.
They used 10 of the 232 articles they found.
Those articles had 1466 patients.
The abstract says both drugs improve subjective and objective daytime sleepiness in res-OSA.
On safety, adverse events tripled.
Adverse events leading to withdrawal doubled.
Serious adverse events did not increase. These mean hospitalisations or death.
Summary of the abstract. The full paper was not read.
Sources
- pubmed-26846828 retrieved 2026-11-18 PMID 26846828